Andres Munoz-De La Rocha
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tezepelumab Reverses TSLP-Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses.
Journal: Allergy
Published: April 27, 2026
Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.
Journal: Frontiers in immunology
Published: January 18, 2023
C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens.
Journal: Current allergy and asthma reports
Published: December 12, 2022
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation.
Journal: Allergy
Published: July 21, 2022
The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
Journal: Communications biology
Published: May 19, 2020
E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
Journal: Scientific reports
Published: February 16, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026